First-in-Human Study of PF-04958242 in Healthy Volunteers
Status:
Completed
Trial end date:
2010-10-16
Target enrollment:
Participant gender:
Summary
The primary objective of this study will evaluate the safety and tolerability of single,
escalating doses of PF-04958242 administered orally to healthy adult participants. This study
will also evaluate the plasma pharmacokinetics (PK) of single doses of PF-04958242 after
single escalating doses of PF-04958242 administered orally to healthy adult participants.